Home Menu

Site Navigation



Parkinson's Disease Tulip

NeuroTalk Support Groups > > >

Neupro(R) (Rotigotine) Provided Clinically Relevant Improvements in Health-Related Qu

 
 
Thread Tools Display Modes
Prev Previous Post   Next Post Next
Old 09-30-2010, 11:59 AM #1
soccertese soccertese is offline
Magnate
  
Join Date: Nov 2007
Posts: 2,532
15 yr Member
soccertese soccertese is offline
Magnate
 
Join Date: Nov 2007
Posts: 2,532
15 yr Member
Default Neupro(R) (Rotigotine) Provided Clinically Relevant Improvements in Health-Related Qu
http://www.marketwatch.com/story/neu...30?siteid=nbkh
soccertese is offline   Reply With QuoteReply With Quote
 

« Previous Thread | Next Thread »

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts
BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Similar Threads
Thread Thread Starter Forum Replies Last Post
UCB Receives Complete Response Letter from U.S. FDA Regarding Neupro® (Rotigotine) Stitcher Parkinson's Disease 0 04-29-2010 09:58 AM
NEWS: UCB Announces The U.S. Launch Of Neupro (Rotigotine Transdermal System) Stitcher Parkinson's Disease 0 07-19-2007 05:16 PM


All times are GMT -5. The time now is 10:27 AM.


Powered by vBulletin • Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise (Lite) - vBulletin Mods & Addons Copyright © 2025 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

All posts copyright their original authors.

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.

Always consult your doctor before trying anything you read here.

Home